BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18298557)

  • 1. Management of MUTYH-associated neoplasia in Australia.
    Worthley DL; Suthers G; Lipton L
    Intern Med J; 2008 Aug; 38(8):644-50. PubMed ID: 18298557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
    Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
    Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUTYH-associated polyposis--from defect in base excision repair to clinical genetic testing.
    Cheadle JP; Sampson JR
    DNA Repair (Amst); 2007 Mar; 6(3):274-9. PubMed ID: 17161978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in-frame exon-skipping MUTYH mutation is associated with early-onset colorectal cancer.
    Fostira F; Papademitriou C; Efremidis A; Yannoukakos D
    Dis Colon Rectum; 2010 Aug; 53(8):1197-201. PubMed ID: 20628285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer and inherited mutations in base-excision repair.
    Chow E; Thirlwell C; Macrae F; Lipton L
    Lancet Oncol; 2004 Oct; 5(10):600-6. PubMed ID: 15465463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
    Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
    Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cells with pathogenic biallelic mutations in the human MUTYH gene are defective in DNA damage binding and repair.
    Parker AR; Sieber OM; Shi C; Hua L; Takao M; Tomlinson IP; Eshleman JR
    Carcinogenesis; 2005 Nov; 26(11):2010-8. PubMed ID: 15987719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.
    Balaguer F; Castellví-Bel S; Castells A; Andreu M; Muñoz J; Gisbert JP; Llor X; Jover R; de Cid R; Gonzalo V; Bessa X; Xicola RM; Pons E; Alenda C; Payá A; Piqué JM;
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):379-87. PubMed ID: 17368238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUTYH hotspot mutations in unselected colonoscopy patients.
    Casper M; Plotz G; Juengling B; Zeuzem S; Lammert F; Raedle J
    Colorectal Dis; 2012 May; 14(5):e238-44. PubMed ID: 22469480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients.
    Croitoru ME; Cleary SP; Berk T; Di Nicola N; Kopolovic I; Bapat B; Gallinger S
    J Surg Oncol; 2007 May; 95(6):499-506. PubMed ID: 17219385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From gene to disease; MutYH-associated polyposis coli (MAP)].
    Nielsen M; Weiss MM; Vasen HF; Hes FJ
    Ned Tijdschr Geneeskd; 2005 Dec; 149(53):2970-2. PubMed ID: 16425850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of the colorectal cancer risk associated with MUTYH mutation.
    Lubbe SJ; Di Bernardo MC; Chandler IP; Houlston RS
    J Clin Oncol; 2009 Aug; 27(24):3975-80. PubMed ID: 19620482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients.
    Steinke V; Rahner N; Morak M; Keller G; Schackert HK; Görgens H; Schmiegel W; Royer-Pokora B; Dietmaier W; Kloor M; Engel C; Propping P; Aretz S;
    Eur J Hum Genet; 2008 May; 16(5):587-92. PubMed ID: 18301448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MutYH (MYH) and colorectal cancer.
    Sampson JR; Jones S; Dolwani S; Cheadle JP
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):679-83. PubMed ID: 16042573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUTYH-associated polyposis.
    Sampson JR; Jones N
    Best Pract Res Clin Gastroenterol; 2009; 23(2):209-18. PubMed ID: 19414147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUTYH-null mice are susceptible to spontaneous and oxidative stress induced intestinal tumorigenesis.
    Sakamoto K; Tominaga Y; Yamauchi K; Nakatsu Y; Sakumi K; Yoshiyama K; Egashira A; Kura S; Yao T; Tsuneyoshi M; Maki H; Nakabeppu Y; Tsuzuki T
    Cancer Res; 2007 Jul; 67(14):6599-604. PubMed ID: 17638869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUTYH mutations associated with familial adenomatous polyposis: functional characterization by a mammalian cell-based assay.
    Molatore S; Russo MT; D'Agostino VG; Barone F; Matsumoto Y; Albertini AM; Minoprio A; Degan P; Mazzei F; Bignami M; Ranzani GN
    Hum Mutat; 2010 Feb; 31(2):159-66. PubMed ID: 19953527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of adenomatous polyposis coli and MUTYH mutations in familial colorectal polyposis.
    De Rosa M; Galatola M; Borriello S; Duraturo F; Masone S; Izzo P
    Dis Colon Rectum; 2009 Feb; 52(2):268-74. PubMed ID: 19279422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUTYH exon 7 and 13 mutations associated with colorectal cancer (MAP syndrome) are not commonly associated with sporadic pancreatic cancer.
    Smith LM; Sharif S; Brand R; Fink E; Lamb J; Whitcomb DC
    Pancreatology; 2009; 9(6):793-6. PubMed ID: 20110747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews.
    Rosner G; Bercovich D; Daniel YE; Strul H; Fliss-Isakov N; Ben-Yehoiada M; Santo E; Halpern Z; Kariv R
    Fam Cancer; 2015 Sep; 14(3):427-36. PubMed ID: 25822476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.